Skip to main content
Premium Trial:

Request an Annual Quote

Dow, Oregon State University Partner on Gene Modification

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Dow AgroSciences and Oregon State University today announced an agreement to use Dow's genome modification technology for tree improvement research.

Researchers at the university will use Dow's Exzact Precision Technology, a toolkit for targeted genome modification, to make changes to essential genes for flowering and reproduction. As part of the deal, Dow is also allowing access to its intellectual property, zinc finger reagents, and scientific expertise.

The research will be directed at tree improvement, "a critical area" for the lumber industry, Dow said. Dow AgroSciences is a wholly owned subsidiary of Dow Chemical.

Financial terms were not disclosed.

The Exzact Precision Technology allows for the editing, addition, or deletion of genes in complete plant genomes for "precise engineering of multi-gene stacks, editing of native gene sequences, and targeted gene disruption in a wide variety of plant species," Dow said in a statement.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.